Long-Term Liabilities: The sum of all non-current liabilities.
Adicet Bio, Inc. (ACET) had Long-Term Liabilities of $11.61M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-30.52M |
|
-- |
|
-- |
|
$31.89M |
|
$-31.89M |
|
$1.37M |
|
$-30.52M |
|
$-30.52M |
|
$-30.52M |
|
$-30.52M |
|
$-30.52M |
|
$-30.52M |
|
$-31.89M |
|
$-31.60M |
|
6.89M |
|
6.89M |
|
$-1.91 |
|
$-1.91 |
|
| Balance Sheet Financials | |
$160.93M |
|
$16.53M |
|
$31.43M |
|
$192.35M |
|
$21.53M |
|
$0.64M |
|
|
Long-Term Liabilities |
$11.61M |
$33.15M |
|
$159.21M |
|
$159.21M |
|
$159.21M |
|
9.59M |
|
| Cash Flow Statement Financials | |
$-95.25M |
|
$2.39M |
|
$75.25M |
|
$59.40M |
|
$41.79M |
|
$-17.61M |
|
$14.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.47 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-96.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.17% |
|
-19.17% |
|
-15.86% |
|
-19.09% |
|
$16.61 |
|
$-14.07 |
|
$-13.82 |
|